Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
COLUMBIA, Md., July 9, 2013 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development and commercialization of unique extracellular matrix products, announced today the launch of a national physician education initiative consisting of educational courses, hands-on training, and peer-to-peer events.
The Company is offering a series of educational courses for physicians to advance their knowledge of regenerative medicine and surgical techniques using the MatriStem extracellular matrix for a variety of indications, including hernia/abdominal wall repair, pelvic floor reconstruction, general surgery, wound care and other indications.
The hands-on sessions include surgical training at multiple locations across the U.S. presented by thought-leading surgeons. Upcoming courses will focus on hernia/abdominal wall repair, reconstructive surgery and pelvic floor repair.
ACell has also established a Speakers’ Bureau of experts in regenerative medicine. These thought-leading surgeons will present at local and regional physician peer-to-peer events, and via webinars, to highlight positive clinical outcomes they have achieved using ACell’s MatriStem extracellular matrix.
“MatriStem represents a true leap forward in our ability to treat patients in a variety of situations that previously would have been difficult to treat,” said Speaker’s Bureau member John Zografakis, M.D. of Akron, Ohio. “The regenerative properties of MatriStem encourage the constructive remodeling of tissue with a unique healing response in both routine and very extraordinary clinical situations.”
Rodney Bosley, ACell President & COO, said, “The launch of this national physician training program is a major step to further expand the use of MatriStem and drive our continued growth. Physicians continue to recognize the unique healing and constructive tissue remodeling characteristics of MatriStem and use it in a wide range of applications. This education initiative is designed to leverage the clinical community’s broad experience with MatriStem to expand awareness and understanding of how it can be used to achieve improved outcomes in both surgical and wound care applications.”
About ACell
ACell, Inc. is a leading developer, manufacturer and marketer of next-generation regenerative medicine products. Its products are cleared for a variety of indications and are marketed under the brand name “MatriStem.” A privately held company, ACell produces MatriStem in its manufacturing facilities and markets its products to physicians in the U.S. through a national direct sales force. For more information, call (800) 826-2926 or visit www.acell.com.
About MatriStem
MatriStem Products consist of porcine-derived extracellular matrix (ECM) that maintain and support a healing environment through constructive remodeling, and are available in particle and sheet forms by prescription only. These devices, trademarked as MatriStem, are appropriate for acute wounds, chronic wounds and various surgical procedures. All MatriStem devices are made in the USA. Refer to IFU supplied with each device for indications, contraindications, and precautions.
Contacts:
Jon Werner
Director of Marketing
(410) 715-1700
Lisa Cook (media)
The Ruth Group
646-536-7012
lcook@theruthgroup.com
SOURCE ACell, Inc.
Help employers find you! Check out all the jobs and post your resume.
